SOLENO THERAPEUT. DL-001 (F:6XC) — Stock Price

€44.86 EUR
▲ 1.70% today

SOLENO THERAPEUT. DL-001 (F:6XC) is currently trading at €44.86 EUR, up 1.70% today. Over the past 52 weeks, shares have ranged between €25.52 and €71.85. This page tracks SOLENO THERAPEUT. DL-001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 6XC company net worth.

SOLENO THERAPEUT. DL-001 (6XC) Stock Price Chart — Daily History & Trading Volume

The chart below tracks SOLENO THERAPEUT. DL-001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

SOLENO THERAPEUT. DL-001 Income Statement — Revenue, Profit & Earnings by Year

SOLENO THERAPEUT. DL-001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €190.41 Million €0.00 €0.00 €0.00 €0.00
Cost of Revenue €2.70 Million €0.00 €0.00
Gross Profit €187.71 Million €0.00 €0.00
Research & Development €40.63 Million €78.57 Million €25.19 Million €15.27 Million €21.45 Million
SG&A €132.13 Million €105.86 Million €13.48 Million €9.84 Million €10.81 Million
Total Operating Expenses €175.46 Million €184.43 Million €38.67 Million €25.11 Million €32.26 Million
Operating Income €14.95 Million €-184.43 Million €-38.67 Million €-25.11 Million €-32.26 Million
EBITDA
EBIT
Interest Expense €5.48 Million €231.00K €0.00 €0.00
Income Before Tax €20.89 Million €-175.85 Million €-38.99 Million €-24.07 Million €-30.91 Million
Income Tax Expense
Net Income €20.89 Million €-175.85 Million €-38.99 Million €-24.07 Million €-30.91 Million

SOLENO THERAPEUT. DL-001 Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes SOLENO THERAPEUT. DL-001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €563.83 Million €330.97 Million €180.69 Million €26.50 Million €35.55 Million
Total Current Assets €355.81 Million €293.89 Million €171.36 Million €15.65 Million €22.42 Million
Cash & Equivalents
Short-term Investments €235.37 Million €203.51 Million €0.00
Net Receivables €28.21 Million €0.00
Inventory €15.02 Million €0.00
Property, Plant & Equipment
Goodwill
Total Liabilities €113.72 Million €85.86 Million €23.18 Million €16.15 Million €17.76 Million
Total Current Liabilities €61.36 Million €18.75 Million €11.51 Million €7.31 Million €8.01 Million
Long-term Debt €49.86 Million €49.83 Million
Net Debt
Total Stockholder Equity €450.12 Million €245.11 Million €157.51 Million €10.35 Million €17.79 Million
Retained Earnings €-431.37 Million €-452.26 Million €-276.41 Million €-237.42 Million €-213.35 Million

SOLENO THERAPEUT. DL-001 Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how SOLENO THERAPEUT. DL-001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €46.80 Million €-69.10 Million €-24.94 Million €-20.78 Million €-27.77 Million
Capital Expenditures €73.00K €218.00K €0.00 €13.00K €22.00K
Free Cash Flow €46.73 Million €-69.31 Million €-24.94 Million €-20.79 Million €-27.79 Million
Investing Cash Flow
Financing Cash Flow €137.16 Million €213.03 Million €180.02 Million €14.09 Million €-128.00K
Dividends Paid
Stock-Based Compensation €45.85 Million €99.96 Million €5.95 Million €2.53 Million €3.28 Million
Depreciation €2.02 Million €1.99 Million €1.96 Million €1.96 Million €1.96 Million
Change in Cash €-17.82 Million €-81.75 Million €155.08 Million €-6.70 Million €-27.92 Million

SOLENO THERAPEUT. DL-001 Earnings History — EPS Actual vs. Analyst Estimates

Track SOLENO THERAPEUT. DL-001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 05, 2026 0.71
May 11, 2026 0.50
Feb 26, 2026 0.34
Nov 04, 2025 0.08
Jun 06, 2025
Mar 04, 2025
Nov 05, 2024
Jun 30, 2022 -0.90 -0.90 +0.00%